| Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression M Moccia, R Lanzillo, R Palladino, KCM Chang, T Costabile, C Russo, ... Multiple Sclerosis Journal 22 (5), 659-667, 2016 | 162 | 2016 |
| Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability A Carotenuto, L Cacciaguerra, E Pagani, P Preziosa, M Filippi, MA Rocca Brain 145 (8), 2785-2795, 2022 | 138 | 2022 |
| Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis R Lanzillo, G Cennamo, C Criscuolo, A Carotenuto, N Velotti, F Sparnelli, ... Multiple Sclerosis Journal 24 (13), 1706-1714, 2018 | 123 | 2018 |
| Communication in multiple sclerosis: pragmatic deficit and its relation with cognition and social cognition A Carotenuto, G Arcara, G Orefice, I Cerillo, V Giannino, M Rasulo, ... Archives of Clinical Neuropsychology 33 (2), 194-205, 2018 | 82 | 2018 |
| The Framingham cardiovascular risk score in multiple sclerosis M Moccia, R Lanzillo, R Palladino, GT Maniscalco, A De Rosa, C Russo, ... European journal of neurology 22 (8), 1176-1183, 2015 | 82 | 2015 |
| The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests F Saccà, T Costabile, A Carotenuto, R Lanzillo, M Moccia, C Pane, ... Multiple Sclerosis Journal 23 (9), 1289-1296, 2017 | 71 | 2017 |
| COVID‐19 pandemic and mental distress in multiple sclerosis: Implications for clinical management T Costabile, A Carotenuto, L Lavorgna, G Borriello, L Moiola, M Inglese, ... European Journal of Neurology 28 (10), 3375-3383, 2021 | 66 | 2021 |
| Oral palmitoylethanolamide treatment is associated with reduced cutaneous adverse effects of interferon-β1a and circulating proinflammatory cytokines in relapsing–remitting … NS Orefice, M Alhouayek, A Carotenuto, S Montella, F Barbato, A Comelli, ... Neurotherapeutics 13 (2), 428-438, 2016 | 61 | 2016 |
| Quality of life and cognitive functions in early onset multiple sclerosis R Lanzillo, A Chiodi, A Carotenuto, V Magri, A Napolitano, R Liuzzi, ... european journal of paediatric neurology 20 (1), 158-163, 2016 | 59 | 2016 |
| The Framingham cardiovascular risk score and 5‐year progression of multiple sclerosis M Petruzzo, A Reia, GT Maniscalco, F Luiso, R Lanzillo, CV Russo, ... European journal of neurology 28 (3), 893-900, 2021 | 55 | 2021 |
| Uric acid: a potential biomarker of multiple sclerosis and of its disability M Moccia, R Lanzillo, R Palladino, C Russo, A Carotenuto, M Massarelli, ... Clinical Chemistry and Laboratory Medicine (CCLM) 53 (5), 753-759, 2015 | 50 | 2015 |
| Anatomical and functional retinal changes in multiple sclerosis G Cennamo, MR Romano, EC Vecchio, C Minervino, C della Guardia, ... Eye 30 (3), 456-462, 2016 | 48 | 2016 |
| Peripapillary vessel density as early biomarker in multiple sclerosis G Cennamo, A Carotenuto, D Montorio, M Petracca, M Moccia, ... Frontiers in Neurology 11, 542, 2020 | 47 | 2020 |
| Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis M Moccia, A Capacchione, R Lanzillo, F Carbone, T Micillo, F Perna, ... Therapeutic advances in neurological disorders 12, 1756286418819074, 2019 | 45 | 2019 |
| Electroencephalographic features in Dravet syndrome: five-year follow-up study in 22 patients N Specchio, M Balestri, M Trivisano, N Japaridze, P Striano, A Carotenuto, ... Journal of Child Neurology 27 (4), 439-444, 2012 | 44 | 2012 |
| Retinal vascular density in multiple sclerosis: a 1‐year follow‐up R Lanzillo, G Cennamo, M Moccia, C Criscuolo, A Carotenuto, ... European Journal of Neurology 26 (1), 198-201, 2019 | 41 | 2019 |
| Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis N Capasso, A Nozzolillo, G Scalia, R Lanzillo, A Carotenuto, ... Multiple Sclerosis and Related Disorders 49, 102802, 2021 | 40 | 2021 |
| Assessment of retinal vascular network in amnestic mild cognitive impairment by optical coherence tomography angiography C Criscuolo, G Cennamo, D Montorio, A Carotenuto, A Strianese, ... PLoS One 15 (6), e0233975, 2020 | 39 | 2020 |
| Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis A Carotenuto, M Moccia, T Costabile, E Signoriello, D Paolicelli, ... Scientific Reports 9 (1), 18074, 2019 | 36 | 2019 |
| Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy R Iodice, A Carotenuto, R Dubbioso, I Cerillo, L Santoro, F Manganelli Journal of the neurological sciences 365, 143-146, 2016 | 36 | 2016 |
